出处
《上海精神医学》
2008年第5期313-315,共3页
Shanghai Archives of Psychiatry
基金
"十五"国家科技攻关项目(2004BA720A21-02)
国家高技术研究发展863计划(2006AA02Z430)
上海市"登山行动计划"((No064119533)
参考文献17
-
1Strous RD, Maayan R, Weizman A. The relevance of neurosteroids to clinical psychiatry: from the laboratory to the bedside. Eur Neuropsychopharmacol, 2006, 16 (3):155-169.
-
2Dubrovsky BO. Steroids, neuroactive steroids and neurosteroids in psychopathology. Prog Neuropsychopharmacol Biol Psychiatry, 2005, 29 (2) :169 -192.
-
3Mukai H, Tsurugizawa T, Ogiue - Ikeda M, et al. Local neurosteroid production in the hippocampus: influence on synaptic plasticity of memory. Neuroendocrinology, 2006, 84 (4) :255 -263.
-
4Stoffel -Wagner B. Neurosteroid metabolism in the human brain. Eur J Endocrinol, 2001, 145 (6) :669 -679.
-
5Hosie AM, Wilkins ME, da Silva HM, et al. Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites. Nature, 2006, 444 (7118) :486-489.
-
6Saalmann YB, Morgan IG, Calford MB. Neurosteroids involved in reg- ulating inhibition in the inferior colliculus. J Neurophysiol, 2006, 96 (6) :3064 -3073.
-
7Basta- Kaim A, Budziszewska B, Jaworska -Feil L, et al. Effects of neurosteroids on glucocorticoid receptor - mediated gene transcription in LMCAT cells--a possible interaction with psychotropic drugs. Eur Neuropsychopharmacol, 2007, 17 ( 1 ) :37 -45.
-
8Muneoka KT, Shirayama Y, Minabe Y, et al. Effects of a neurosteroid, pregnenolone, during the neonatal period on adenosine Al receptor, dopamine metabolites in the fronto - parietal cortex and behavioral response in the open field. Brain Res, 2002, 956 (2) : 332 - 338.
-
9Gizerian SS, Morrow AL, Lieberman JA, et al. Neonatal neurosteroid administration alters parvalbumin expression and neuron number in medial dorsal thalamus of aduh rats. Brain Res, 2004, 1012( 1 -2) : 66 - 74.
-
10Hashimoto K, Fujita Y, Iyo M. Phencyclidine- induced cognitive deficits in mice are improved by subsequent subchronic administration of fluvoxamine: role of sigma - 1 receptors. Neuropsychopharmacology, 2007, 32(3) : 514 -521.
同被引文献5
-
1赵程,于会艳,李薇,时晶,秦斌.帕金森病患者肠道菌群变化的研究[J].中华神经科杂志,2018,51(7):498-503. 被引量：17
-
2孙根,朱红灿,祝清勇.肠道菌群与帕金森病[J].河南医学研究,2018,27(4):639-641. 被引量：1
-
3韩秋琴,万国庆,顾雪锋.鱼藤酮诱导帕金森病模型小鼠体内肠道微生物的变化[J].解剖学报,2020,51(4):507-512. 被引量：4
-
4Agata Mulak,Bruno Bonaz.Brain-gut-microbiota axis in Parkinson's disease[J].World Journal of Gastroenterology,2015,21(37):10609-10620. 被引量：67
-
5Adreesh Mukherjee,Atanu Biswas,Shyamal Kumar Das.Gut dysfunction in Parkinson's disease[J].World Journal of Gastroenterology,2016,22(25):5742-5752. 被引量：27
二级引证文献1
-
1肖琪,樊慧杰,李艳荣,孙芮芮,贾璐,徐磊,尉杰忠,肖保国,马存根,柴智.帕金森病发病机制研究进展[J].解放军医学杂志,2023,48(8):983-992. 被引量：9
-
1蔡明,朱嗣恒,王强,胡萍.抗精神病药物对于肝功能的影响[J].中国医药指南（学术版）,2007,5(12X):655-655. 被引量：2
-
2翟书涛.甲状腺激素与人类行为[J].国外医学（精神病学分册）,1989,16(1):65-70. 被引量：13
-
3黄继忠,张明园.非典型抗精神病药治疗精神分裂症的评价(一)[J].上海精神医学,2005,17(4):230-232. 被引量：3
-
4孙爱真.急性脑血管病并发急性心肌梗塞10例护理体会[J].菏泽医学专科学校学报,1998,10(4):74-74.
-
5秦红.新型抗精神病药维思通与阿立哌唑比较[J].基层医学论坛,2006,10(5):426-427.
-
6吴文辉,许丽珍.凝血酶致脑水肿的实验观察[J].中国血液流变学杂志,2003,13(2):130-134. 被引量：6
-
7庞乃山.我院精神药物临床应用调查分析[J].哈尔滨医药,2013,33(3):200-201. 被引量：1
-
8周天红,孙凌.阿立哌唑在儿童精神障碍中的应用[J].天津药学,2011,23(2):59-63. 被引量：6
-
9王滟,刘治军,迟家敏.非典型抗精神病药物与代谢综合征[J].中国全科医学,2007,10(6):474-475. 被引量：6
-
10刘小飞,林建敏,李芊芊.我院2013-2014年门急诊抗精神障碍药处方分析[J].中国药房,2015,26(35):4928-4930. 被引量：6
